SCHEMBL9722967

SCHEMBL9722967

CNc1cc(F)ccc1C(=O)CCl

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.42
MAPK1 P28482 1/20 0.42
HIF1A Q16665 1/20 0.42
RAB9A P51151 3/20 0.42
HTT P42858 3/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
MITF O75030 1/20 0.42
IKBKB O14920 1/20 0.39
CES2 O00748 2/20 0.39
CES1 P23141 2/20 0.39
CLCN2 P51788 1/20 0.39
ACKR3 P25106 1/20 0.39
YAP1 P46937 1/20 0.39
TEAD4 Q15561 1/20 0.39
TEAD2 Q15562 1/20 0.39
HPGD P15428 1/20 0.39
GSK3B P49841 2/20 0.37
MAPT P10636 1/20 0.36
NPC1 O15118 1/20 0.36
KDM4E B2RXH2 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27731731 0.85 HSP90AB1 (0.43) ALDH1A1HTTSMN1; SMN2IKBKBCES2
SCHEMBL9722911 0.81 IKBKB (0.38) ALDH1A1HTTSMN1; SMN2IKBKBCES2
SCHEMBL9722960 0.80 MRGPRX1 (0.37) SMN1; SMN2IKBKBCES2CES1CLCN2
SCHEMBL9722931 0.79 CES2 (0.44) HTTIKBKBCES2CES1CLCN2
SCHEMBL3810854 0.79 CLCN2 (0.52) ALDH1A1HIF1AIKBKBCES2CES1
SCHEMBL10631588 0.78 KMT2A (0.38) SMN1; SMN2IKBKBCES2CES1CLCN2
SCHEMBL10481312 0.78 ALDH1A1 (0.38) ALDH1A1SMN1; SMN2IKBKBCES2CES1
SCHEMBL6535624 0.78 IKBKB (0.36) HTTSMN1; SMN2IKBKBCES2CES1
SCHEMBL14627554 0.77 FFAR4 (0.36) ALDH1A1RAB9AHTTSMN1; SMN2IKBKB
SCHEMBL2597507 0.77 CES2 (0.61) ALDH1A1MAPK1HIF1ARAB9AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5079264-A CHEMICAL PROCESS THE BOOTS CO. PLC (GB) 1992-01-07 US disclosed
EP-0317149-B1 PROCESS FOR THE SYNTHESIS OF 3-THIO-4-QUINOLONE DERIVATIVES AND INTERMEDIATE COMPOUNDS FOR USE THEREIN, AND THEIR USE AS MEDICAMENTS The Boots Company PLC (GB) 1991-11-06 EP disclosed
US-5011931-A For treatment of cardiovascular disorders; hypotensive agents THE BOOTS COMPANY PLC (GB) 1991-04-30 US disclosed
WO-1989004827-A1 PROCESS FOR THE SYNTHESIS OF 3-THIO-4-QUINOLONE DERIVATIVES AND INTERMEDIATE COMPOUNDS FOR USE THEREIN, AND THEIR USE AS MEDICAMENTS THE BOOTS COMPANY PLC (GB) 1989-06-01 WO disclosed